PMID- 37084957 OWN - NLM STAT- MEDLINE DCOM- 20230816 LR - 20230817 IS - 1872-9428 (Electronic) IS - 0166-6851 (Linking) VI - 255 DP - 2023 Sep TI - Designing a multi-epitope chimeric protein from different potential targets: A potential vaccine candidate against Plasmodium. PG - 111560 LID - S0166-6851(23)00018-X [pii] LID - 10.1016/j.molbiopara.2023.111560 [doi] AB - Malaria is an infectious disease that has been a continuous threat to mankind since the time immemorial. Owing to the complex multi-staged life cycle of the plasmodium parasite, an effective malaria vaccine which is fully protective against the parasite infection is urgently needed to deal with the challenges. In the present study, essential parasite proteins were identified and a chimeric protein with multivalent epitopes was generated. The designed chimeric protein consists of best potential B and T cell epitopes from five different essential parasite proteins. Physiochemical studies of the chimeric protein showed that the modeled vaccine construct was thermo-stable, hydrophilic and antigenic in nature. And the binding of the vaccine construct with Toll-like receptor-4 (TLR-4) as revealed by the molecular docking suggests the possible interaction and role of the vaccine construct in activating the innate immune response. The constructed vaccine being a chimeric protein containing epitopes from different potential candidates could target different stages or pathways of the parasite. Moreover, the approach used in this study is time and cost effective, and can be applied in the discoveries of new potential vaccine targets for other pathogens. CI - Copyright (c) 2023. Published by Elsevier B.V. FAU - Devi, Sanasam Bijara AU - Devi SB AD - Department of Life science & Bioinformatics, Assam University, Silchar 788011 India. Electronic address: jarasanasam@gmail.com. FAU - Kumar, Sanjeev AU - Kumar S AD - Department of Life science & Bioinformatics, Assam University, Silchar 788011 India. LA - eng PT - Journal Article DEP - 20230420 PL - Netherlands TA - Mol Biochem Parasitol JT - Molecular and biochemical parasitology JID - 8006324 RN - 0 (Malaria Vaccines) RN - 0 (Epitopes, T-Lymphocyte) RN - 0 (Recombinant Fusion Proteins) SB - IM MH - Animals MH - Molecular Docking Simulation MH - Plasmodium falciparum/genetics MH - *Malaria Vaccines/genetics MH - Epitopes, T-Lymphocyte/genetics/chemistry MH - *Plasmodium MH - *Parasites MH - Recombinant Fusion Proteins/genetics MH - Computational Biology OTO - NOTNLM OT - Chimeric protein OT - Malaria OT - Peptide vaccine OT - Plasmodium falciparum OT - Reverse vaccinology COIS- Declaration of Competing Interest The authors declare no conflicting interest in publishing the article. EDAT- 2023/04/22 10:42 MHDA- 2023/08/16 06:42 CRDT- 2023/04/21 19:28 PHST- 2022/07/13 00:00 [received] PHST- 2023/03/30 00:00 [revised] PHST- 2023/04/03 00:00 [accepted] PHST- 2023/08/16 06:42 [medline] PHST- 2023/04/22 10:42 [pubmed] PHST- 2023/04/21 19:28 [entrez] AID - S0166-6851(23)00018-X [pii] AID - 10.1016/j.molbiopara.2023.111560 [doi] PST - ppublish SO - Mol Biochem Parasitol. 2023 Sep;255:111560. doi: 10.1016/j.molbiopara.2023.111560. Epub 2023 Apr 20.